Aducanumab is the first new dementia drug treatment to come to market since 2003.
Featured news and events
The report launch of From Plan to Impact IV: Progress towards targets of the WHO Global action plan on dementia will take place virtually on 26 May.
On World Alzheimer's Day, a doctor who diagnosed her own dementia after being misdiagnosed by her neurologist, is calling for an urgent response to dementia research and diagnosis.
In partnership with ITN Productions, ADI has released the documentary film ‘Every 3 seconds’ to help raise awareness on the global impact of dementia.
The World Health Organization (WHO) has published new materials around the Global action plan on dementia, produced in partnership with ADI.
New research published in The Lancet shows that as many as one in three cases of dementia could be prevented if all factors were addressed.
The 4th Regional non-Latin Caribbean Conference on Alzheimer’s and Dementia was hosted by the Alzheimer's Association of Trinidad and Tobago and ADI in Port of Spain.
ADI is excited to announce that Paola Barbarino has been appointed as our new CEO. Paola will assume the role on 15 May 2017, after which there will be a period of transition alongside outgoing Executive Director, Marc Wortmann. Marc will be leaving his position after more than ten years…
The government of Indonesia has announced the launch of its national dementia plan during a ceremony at the Ministry of Health.
Smokers have a 45% higher risk of developing dementia than non-smokers according to information published by ADI and WHO.